X-Ray Diffraction Powder Date for Steroids - ACS Publications

WILLIAM T. BEHER, JONATHAN PARSONS, and GIZELLA D. BAKER. The Edsel B. Ford Institutefor Medical Research, Henry Ford Hospital, Detroit 2, Mich...
0 downloads 0 Views 3MB Size
X-Ray Diffraction Powder Data for the Steroids WILLIAM T. BEHER, JONATHAN PARSONS, and GIZELLA D. BAKER The Edsel

B. Ford Institute for M e d i c a l Research,

Henry Ford Hospital, Detroit 2, M i c h . ~

X-ray diffraction powder data and powder diffraction photographs for 39 steroids are presented.

Table I. 52

(deoxycorticosterone acetate) Allopregnane-2 1-01-3,20-dione-2 l-acet a t e ( 2 1-acetoxyallopregnanedione) A'-Pregnene-3,20-dione-21-01 (deoxycorticosterone) A'-Pregnene-3,20-dione-17-01 (17-hydroxyprogesterone)

53

S

ISCE the publication of the previous paper (3) on x-ray diffraction data for steroids, a number of additional com-

54 J5

pounds have become available for study. The data and diffraction patterns obtained are here presented. The procedure followed was identical with that outlined in the previous paper (3) with the exception of the method of deteimining relative intensities. The relative intensities, which are presented with these 39 patterns, were measured using a technique of graded intensity scale comparison, developed by HannWalt, Rinn, and Frevel ( 1 ) and modified by Klug and Alexander

K. Kl

K3

L. Dihydroxytriketones A'-Preenene-3.11.20-trione-l7iu)21A'-Pregnene-3,11,20-trione-I7(u) $1diol ?cortisone) (cortisone) A'-Pregnene-I7(a) ,21-diol-3,11,20-tn,21-diol-3,11,20-trione-21-acetate (cortisone acetate)

L1

L2

Table I. Pattern No.

Index to X-Ray Diffraction Powder Data on Steroids

Name C~Q-Z STEROIDS Q 4 . llonochloro 3(B)-Chloro-A~-cholestene (cholesteryl chloride) B. Monohydric Alcohols 3(p)-Cholestane-3-acetate (dihydrocholesterol acetate) 22,23-Dihydrostigmas terol-3-acetate (B-sitos terol acetate) Stigmasta-Ab,*2-dien-3(p)-ol-3-acetate (stigmasterol acetate) As-Cholestene-3-01-3-acetate (cholesterol acetate)

M.P. JUncor.), C.

B1 B2 B3 B4

92

-217

207

-210

236

-237.5

195.5-197.5

222

-225

236

-240

S1 s 2 53 x5

111. STEROIDSAPOGLXINS A N D DERIVATIVES Sarsasapogenin 198 -201 Diosgenin acetate 195 -197 Cholesterol digitonide ... 8-Sitosterol digitonide . . 45-Androstene benzoate digitonide

01 02 03

Gitoxin Digoxin Digitoxin

>-4

108 -109

215

11. BILE ACIDS Hyodeoxycholic acid Lithocholic acid (3u-hydroxycholanic acid)

A12

-94

-196

138 -141

RI 1

I.

.I 1

155 -157 104

Dihydroxydiketones

A'-Pregnene-l*i(a) .21-diol-3,20-dione [Reichstein's Substance S (alcohol) ] Ad-Pregnene-l7(~),21-dio1-3,20-dione-21acetate [Reichstein's Substance 9 (acetate) ] Pregnane-l7(u) ,2 l-diol-3,20-dione-Z1acetate

K2

(2).

(Continued)

A'-Pregnene-3,2O-dione-21-01-2l-acetate

185 -187

IT. DIGITALIS GLYCOSIDES

125 -127 140 -141.5

Dec. 282 260 -265 245 -249

115 -116

C.

C1 c2 C3

Dihydric .4lcohols Pregnane-a(u) ,ZO(u)-diol Pregnane-3(a) 2 0 (@)-diol 17(a)-Methyl- As-andros tene-3 (0).17 ( B ) diol (mestenediol) D.

D1

Table 11. X-Ray Diffraction Powder Data

237 -230 232,5-235 204

d, 4 .

Monoketones

Cholestane-3-one (cholestanone)

F1 F2

Diketones Pregnane-3,20-dione (pregnanedione) F . Monohydroxymonoketones Allopregnane-3(p)-o1-20-one (allopregnanolone) Ab- Andros tene-3 (0) -01- 17-one-3 methyl ether (dehydroepiandrosterone methyl -the?\

15.4 10.5 7.90 6.89 6.13 5,49 4.66

117 -120

H1

H. Trihydroxymonoketones A4-Pregnene- 17a,?Oh,2I-triol-3-one!Oh,21-diacetate (17a-pregnentriolone diacetate)

188 -190.3

I1

I. Tetrahydroxymonoketones 3(u),17(u),11 (p),ZI-Tetrol-pregnane-ZOone (tetrahydrocortisone)

216

G1

G2 G3

J1

117.5-120 173 -175

163

-165

185 -189 -2i6

-2I8

5. Monohydroxydiketones 16,17-0xido-A~-pregnene-3,20-dione-21ol-21-acetate (16.17-epoxydeoxycorticosterone acetate)

166 -168

1569

3(8)-Cholestane3-acetate 16.7 0.20 10.0 O,l5 9.02 0.07 7.47 0.15 0.07 6.81 1.00 6.09 5.72 0 50 5.31 0.27 4.89 0.27 4.68 0.37 4.47 0.27 4.18 0.37 3.81 0.20 3.55 0.20 3.28 0.15 3.07 0.20 2.89 0.20 2.79 0.10 2.68 0.15 2.51 0.15 2.41 0.10 2.26 0 20 2.20 0.15 2.04 0 15 1.90 0.15 1.83 0.03 0.01 1.77 1.72 0.01 1 ..SI 0.01

llonohydric Alcohols B2. 22.23-Dihydrostigmasterol-3-acetate 12.8 0.13 6.40 0.07 6.07 1.00 5,74 0.20 5.42 0.02 5.10 0.53 4.86 0.40 4.16 0.02 3.75 0.20 3.51 0.02 3.10 0.20 3.02 0.13 2.94 0.07 2.60 0.02 2.43 0.03 2.14 0.07 2.02 0.07 1.94 0.02 B3. Stigmasta-Ajr22dien-3(s)-ol-3-acetate 16.5 0.04 10 2 0.04 9.21 0.20 7.60 0.04 7.03 0.49 8.19 0.36 5 75 0.13 5:44 0.13

d , A.

I/Ii

2.78 2.58 2.49 2.27 2.16 2.05 1.93

0.03 0.02 0.07 0.13 0.07 0.13 0.02

B. B1.

137.5-140.5

272

F4

0.13 0.53 0.13 0.20 0.40 1.00 0.53

192 -1q5

I/Ii C~Q-A STEROIDS Q

.1. blonochloro 3(f3)-Chloro-As-cholestene 4.32 0.20 3.95 0.30 3.78 0.07 3.54 0.30 3.21 0.03 $07 0.03 -.94 0.03

Al.

128 -129

~4I.~nd;ostene-17(8)-01-3-one~17-propionate (testosterone propionate) AS t '6-Pregnadiene-3 (B)-ol-20-one-3-acet a t e (16-dehydropregnenolone acetate) G. Dihydroxymonoketones Ab-Pregnene-3 (p), 2 l-diol-20-one-3.21diacetate (21-acetoxypregnenolone acetate) 16.17-0xido-A5-pregnene-3(p) ,21-diol20-one-2 1-acetate (16,17-epoxy-21acetoxypregnenolone) As-Pregnene-3(@), 17-diol-20-one (17hydroxypregnenolone)

F3

d , A.

I.

E.

El

I/I,

-205

B 3. Contd. 5.10 0.13 1.00 4.87 4.66 0.20 4.30 0.13 4.12 0.13 3.98 0.13 3.87 0.13 0.13 3.78 3.74 0.27 3.59 0.13 0.13 3.38 3.26 0.13 3.10 0.13 3.02 0.01 2.94 0.01 2.78 0.01 0.13 2.57 0.13 2.50 0.13 2.39 2.34 0.13 2.28 0.20 2.21 0.13 2.14 0.01 2.09 0.20 2.00 0.01 1.94 0.01 0.02 1.88 1.82 0.02 1.78 (Continued on p a g e 1 6 7 1 )

ANALYTICAL CHEMISTRY

1570

.

...

...._* -

,

Figure 1. X-ray diffraction powder patterns of steroids Key found in Tabla

V O L U M E 2 7 , NO. 10, O C T O B E R 1 9 5 5

1571

Table 11. X-Ray Diffraction Powder Data (Continued) d , A.

I/Ii B4.

d , A. 1/11 d , A. A5-Chokatene-3-01-3-acetate 4.13 3.70 3.53 3.12 2.97 2.88 2.75 2.65 2 47 2.39

16.36 13.81 10.40 8.23 7.06 6.17 5.42 4.77 4.58 4.33

C. Pregnane-S(a), 20(a)-diol 0.38 12.3 0.38 9.46 0.38 7.83 7.03 0.75 6.33 0.25 5.79 1.00 0.25 5.35 1.00 5.08 0.75 4.68 4.42 0.03 4.12 0.56 0.03 3.93 0.38 3.79 3.46 0.38 3.17 0.06 0.03 3.08 0.03 2 95 0.25 2.55 2.48 0.25 2.41 0.25 2.30 0.03 2.15 0.38 0.03 2.06 2.01 0.03 0.13 1.97

c1.

0.27 0.37 0.27 0.20 0.15 0.10 0.10 0.10 0.20 0.20

C2.

Pregnane-a(a),20(8)-diol

11.6 10.5 9.07 8.39 7.17 6.44 5.83 5.32 4.87 4.49 4.14 3.92 3.69 3.68 2.71 2.52 2.35 2.21

0.55 0.05 0.27 0.55 0.55 0.55 0.73 1.00 0.41 0.41 0.41 0.41 0.41 0.05 0.02 0.02 0.02 0.02

d , A.

1/11

C3. 17(a ) - M e t hyl- Asandrostene-3(8),17(8)diol 12.1 0.13 10.5 0.13 9.46 0.03 8.47 0.07 7.09 0.30 6.37 0.53 5.75 1.00 5.38 0.53 4.85 0.40 4.53 0.30 4.32 0.40 4,l5 0.30 3.78 0 20 3.56 0.30 3.29 0.30 3.11 0.03 2.99 0.03 2.84 0.40 2.70 0.02 2.53 0.02 2.43 0.03 2.16 0.02 2.08 0.03

1/11

D.

hlonoketonm Cholestane-3-one 0.13 0.13 0.01 0.27 0.09 0.13 0.13 0.13 1.00 0.67 0.27 0.20 0.20 0.13 0.13 0.20 0.20 0.01 0.01 0.01 0.13 0.04 0.04 0.04 0.02 0.01 0.01

16.7 12.7 11.3 9.66 8.59 7.87 7.34 6.45 5.54 4.95 4.56 4.21 3.92 3.68 3.51 3.37 3.23 3.08 3.00 2.90 2.54 2.45 2.38 2.30 2.22 2.09 1.99

E. El.

F2. As-Androstene3tp)-ol-li-one-3 methyl ether 0.11 11 2 0.20 9 35 7 83 0.010.53 6.76 1.00 6.26 0.11 5 74 0.20 5.20 0.20 4 66 0.53 4.42 0.11 4.23 0.11 4 08 3.88 0.08 0.08 3.70 0.11 3 58 0.15 3.39 0.11 3.28 0.15 3.09 0.11 2 92 0.012 78 0.08 2.69 2.55 0.08 2.41 0.11 0.012.32 2.22 0.15 0.01 2.10 0.01 2.07 2.01 0.08 1 91 0.15 1.81 0.01 1.79 0.01 1.76 0.011.70 0.011.65 0.011.63 0.01 0.011.57 0.011.50

Allopregnane3(p)-ol-ZO-one

8.59 6.66 6.33 5.70 5 49 5.15 4.89 4.65 4.44 4.21 4.10 3.80 3.68 3.49 3.29 3.19 2.99 2.77 2.44 2.38 2.25 2.18

0.30 0.30 0.40 1.00 0.30 0.02 0.53 0.02 0.02 0.53 0.30 0.02 0.02 0.40 0.13 0.03 0.03 0 03 0.30 0.30 0.07 0.30

F4.

D1.

d . A. I/Il d , A. f. Monohydroxymonoketones

F1.

Dihydric .4lcohols

d , A.

10.3 6.56 6.28 5.79 5.56 5.11 4.46 3.91 3.53 3.40 3.13 2.97 2.88 2.77 2.67 2.53 2.43 2.39 2.23 2.16 2.10 2.01 1.96

I'Ii

Diketones

Pregnane-3,ZO-dione 0.20 0.20 1.00 0.73 0.73 0.53 0.53 0 20 0.40 0.13 0.07 0.13 0.07 0.07 0.07 0.03 0.07 0.03 0.07 0.13 0.03 0.03 0.13

Ij11

F3. A'-Androstene17(p)-01-3-one- 17propionate 10.8 0.36 7.54 0.27 7.14 0.36' 6.09 1.00 0.67 5.49 0.13 5.08 0.04 4.84 0.67 4 71 0.27 4.40 4.22 0.04 0.27 3.97 0.27 3.87 0.01 3.73 0.27 3.60 0.27 3.45 0.09 3.24 0.09 3.11 0.27 2.95 2.87 0.13 0.13 2.80 0.09 2.73 0.09 2.68 2.60 0.09 2.55 0.09 2.50 0.02 2.45 0.04 0.04 2.41 0.04 2.37 2.28 0.27 0.02 2.22 0.27 2,15 2.01 0.04 2.01 0.02 0.02 1.98 0.02 1.94

A5,16-Pregnadiene-3(p)-o1-20-one-3-acetate

19.0 11.6 9.36 6.89 6.33 6.17 5.77 5.50 5.35 5.05 4.67 4.52 4.33 4.13 3.94 3.85 3.69

3.58 3.49 3.41 3.34 3.16 3.07 3.01 2.88 2.77 2.73 2.66 2 59 2.50 2.43 2.36 2.31 2.28 G.

2.23 2.17 2.13 2.07 2.01 1.96 1.93 1.89 1.85 1.77 1.74 1.71 1.66 1.62

0.18 0.18 0.02 0.09 0.09 0.02 0.18 0.09 0.09 0.09 0.02 0.02 0.02 0.02

Dihydroxymonoketones

G1. AS-Pregnene-3(8), 21-diol-20-one 3,21G2 (Contd.) diacetate 5 67 0.30 15.5 0.13 7.83 0.07 5.37 0.53 6.61 0.02 5.04 0.53 6.09 0.73 4 65 * 0.40 5.64 0.53 4 29 0.53 4 10 0.53 5.33 0.30 5.19 0.30 3.92 0.40 5.00 0.13 3 56 0.02 4.75 1.00 3.37 0.53 4.45 0.13 3.27 0.02 4.28 0.07 3.19 0.02 3.90 0.40 3.08 0.30 3.76 0.40 2.92 0.02 3.56 0.40 2 83 0.07 3.40 0.07 2.75 0.13 2.70 0.13 3.03 0.30 2.85 0.30 2.58 0.02 2.74 0.13 2.54 0.02 2.60 0.07 2 39 0.07 2.51 0.07 2 33 0.07 2.41 0.02 2.18 0.13 2.36 0.07 2 04 0.07 2.28 0.07 1 96 0.02 2.21 0.07 1.82 0.02 2.15 0.02 2.08 0.07 G3. A5-Pregnene-3(@), 2.11 0.07 17-diol-20-one 2.01 0.02 12 1 0.27 1.93 0.02 8.01 1.00 1.84 0.02 5 83 1.00 5 06 0 .75 G2. 16,17-0xido-A64.88 0.21 pregnene-3 (8),21-diol4 . 6 2 0 . 27 20-one-2 1-acetate 4.30 0.75 9.35 0.73 4.08 0.20 6.15 1.00 3.75 0.10

G3. ( C o n t d . ) 3.62 0.20 3.52 0.10 3.40 0.15 3.31 0.15 3.17 0 1.5 3.08 0.15 3.00 0.2i 2.92 0 15 2.86 0.15 2.82 0 15 2.74 0 10 2.68 0 15 2.57 0.03 2.47 0.03 2.42 0.02 2 38 0 07 2.36 0.03 2.30 0.07 2.28 0.07 2.21 0.03 2.13 0.01 2.08 0.20 2 04 0.20 2.01 0.01 1.99 0.20 1.95 0 20 1.92 0.01 1.90 0.01 1.88 0 01 l,85 0.07 1.83 0.03 1.74 0.03 1.68 0.03 1.64 0.02 1.57 0.01 1.54 0.01 1.52 0.03 1.47 0.01 1.45 0.01

ANALYTICAL CHEMISTRY

1572

Table 11. X-Ray Diffraction Powder Data (Continued) d , A.

HI.

d , A. I/Il H. Trihydroxymonoketones A~-Pregnene-17a,20b,2l-triol-3-one-2Ob,2l-diacetate

I/Il

11.19 8.55 7.14 6.28 5.79 5.50 4.65 4.28 4.08 3.87 3.72 3.58 3.45 3.32 3.24

11.

3.14 3.06 2.92 2.81 2.70 2.60 2.40 2.21 2.15 2.08 2.01 1.92 1.83 1.76

54.

0.15 0.15 0.09 0.10 0.10 0.09 0.15 0.09 0.09 0.10 0.04 0.04 0.02 0.01

I. Tetrahydroxymonoketones 3 ( a ) ,17(a),11@),2l-Tetrol-pregnane-20-one 2.89 2.82 2.76 2.67 2.55 2.50 2.44 2.30 2.24 2.23 2.16 2.11 2.06 1.98 1.93 1.89 1.85 1.81

1/11 d , A. 1/11 J. Monyhydroxydiketone (Contd.) 44-Pregnene-3,20-dione-21-01 55. 34-Pregnene-3,20-dione-17-01 11.7 0.06 11.4 0.08 6.54 0.08 5.91 1.00 5.45 0.20 4.90 0.30 4.54 0.20 0.06 4.19 0.20 4.10 0.06 3.92 0.20 3.63 0.04 3.48 0.04 3.36 0.06 3.26 0.11 3.12 0.013.04 2.84 0.06 0.11 2.66 2.52 0.11 2.46 0.04 2.34 0.11 0.11 2.31 0.03 2.22 0.08 2.10 2.01 0.03 0.08 1.96 0.01 1.91 0.08 1.86 0.01 1.81 0.01 1.75 1.64 0.06 0.06 1.54 0.03 1.39 1.25 0.01d,

0.13 0.02 0.13 0.13 0.07 0.03 0.40 0.40 0.13 0.02 0.13 0.13 0.07 0.13 0.02 0.02 0.02 0.07

d , .I.

.I.

I/ll

K. ICl. d , A.

d , -4.

1/11 J.

J1. 16,17-0xido-A(pregnene-3,20-dione-2101-21-acetate 0.13 0.13 0.20 0.03 0.03 1.00 0.73 0.53 0.53 0.03 0.53 0.07 0.03 0.02 0.03 0.13 0.20 0.07 0.07 0.07 0.02 0.02 0.40 0.13 0.07 0.03 0.03 0.13 0.13 0.13 0.02 0.13 0.02

I/Ii

d , A.

I/Ii

Monohydroxydiketones 52. 4a-Pregnene-3,20dione-21-01-21-acetate 11.4 0.13 8.23 0.13 7.23 0.27 6.23 0.27 0.04 5.89 0.m 5.59 1.00 5.33 0.27 5.11 0.27 4.90 4.62 0.27 4.50 0.02 4.37 0.27 4.20 0.36 3.98 0.02 3.81 0.09 3.60 0.36 3.38 0.01 3.24 0.20 3.15 0.20 3.00 0.20 0.20 2.93 2.81 0.20 2.74 0.20 2.65 0.01 2.57 0.20 2.48 0.20 2.43 0.20 2.35 0.20 2.30 0.01 0.20 2.26 2.21 0.20 2.16 0.02 0.13 2.01 1.98 0.01 0.01 1.84

53. Allopregnane-2 1ol-3,20-dione-21acetate 7.00 6.68 6,56 6.33 6.19 5.79 5.22 5.10 4.94 4.68 4.59 4.39 4.13 3.87 3.75 3.63 3.54 3.43 3.33 3.24 3.09 3.04 2.98 2.94 2.82 2.72 2.65 2.61 2.56 2.52 2.48 2.38 2.25 2.20 2.18 2.15 2.12 2.08 * 2.04 2.00 1.96 1.87 1.77 1.66

A'-Pregnene-l7(a). 2 l-diol-3,20-dione 10.9 0.05 8.35 0.09 6.33 0.73 5.59 1.00 5.29 0.73 4.58 0.02 4.33 0.02 4.17 0.73 0.05 3.66 0.02 3.71 0.27 3.69 0.18 3.40 0.18 3.29 0.41 3.18 0.27 3.08 0.09 2.96 0.09 2.81 2.67 0.18 2.59 0.27 2.40 0.27 0.02 2.23 0.18 2.18 0.09 2.09 0.18 2.04 0.02 2.00 0.02 1.96 0.02 1.89 0.09 1.84 0.02 1.79 0.09 1.69

d , A. 1/11 d , b. I/Ii Dihydroxydiketones K2. A4-PregneneK3. Pregnane-lT(a) .2117(a),21-diol-3,20diol-3,20-dione-21dione-21-acetate acetate 11.1 13.1 8.31 6.89 7.23 6,56 6.24 6.24 5.91 5.85 5.59 5.70 5.50 5.32 5.22 5.10 4.87 4.93 4.68 4.80 4.42 4.52 4.39 4.25 4.21 4.18 3.82 4.09 3.96 3.60 3.24 3.85 3.13 3.75 3 04 3.64 2.94 3.47 2.84 3.33 2.75 3.28 2.71 3.18 2.66 3.12 2.62 3 06 2.98 2.55 2.92 2.47 2.83 2.34 2 30 2 74 2.24 2 67 2.19 2 62 2 , 26 2.58 2.11 2.53 2.06 2.47 2.01 2.44 2.40 1.98 2.36 1.93 2.31 1,87 2.27 1.82 2.21 1 77 2 15 1.73 2.09 2.05 1.98 1.95 1.91 1.87 1.83 1.80 1.74 1.68 1.59 1.53

V O L U M E 27, NO. 10, O C T O B E R 1 9 5 5

1573 ________~~

~__

Table 11. X-Ray Diffraction Powder Data (Continued) d , A.

III; L.

d , A:

111.

I[. Hyodeoxycholic w i d 14.6 0.20 0.13 1O.Y 9.21 0.53 0.40 7.63 0.13 6.26 1.00 6.83 0.40 5.59 0.40 5,29 4.91 0.53 4.51 0.33 0.30 4.27 4.11 0 40 0.07 3.95 0.40 3.73 0.07 3.60 0.40 3.41 0.30 3 25 0.30 3.13 0 . 20 3.04 0.07 2.86 0.07 2.76 0.13 2.70 0.13 2.01 2 . .55 0 0: 2.47 0.30 2.40 0.30 0.30 2.34 0 30 2.22 2.15 0.13 2.10 0.18 2.00 0.30 0.13 1.99 0.13 1.88

13.1 9 07 7.23 0.13 6 . 15 5.81 5 01 5.39 5.05 4 76 4.48 4 32 4.20 4.03 3.88 3.74 3.57 3 46 3.3li 3.23 3 . 10 2.90 2.80 2 0.; 2 56 2 48 2 3.5 2.26 2 23 2 lli 2 OR 2 03 1.98 1 90 1.87 1.82 1.74 1.66

d , A. IIII d , A. I/Ii 111. STEROIDSAPOGEKIXS A X D DERIV.%TIYEB (Contd.) N l . (Contd.) N2. (Contd.)

I/I:

Dihydrovytriketonez L I . 34-Pregnene-3.1 1,20-trione17(o1),21-diol L2. (Contd.) 4 , ti> 0 10 4.29 0 li 4.15 0 03 4.00 0 10 0 0: 3.83 0 211 3.73 0 0-7 3.58 0 15 3 43 0 15 3.32 0 10 3.11 0 IO 3.06 0 10 2.97 2 89 o zn 0 02 2 74 2.07 0 07 2.64 0 01 2.58 0 0! 0 0: 2 52 0 07 2.43 0 07 2 38 0 0: 2 30 0 li 2.21 0 01 2.17 0 03 2 12 0 02 2.07 0 02 2.05 0 10 1.99 I.?. ~'-Preenene-l'i(cr),Zi-diol0 03 1.94 3 11.20-trione-21-acetate 0 03 1 91 7 34 0 1.7 1.86 0 0' 6 19 o 50 0 07 1.82 5 93 0 37 0 03 1.74 5 49 0 Ii 0 03 1.73 0 07 5 10 0 03 1 68 1 6 4 0 03 4 94 1 00

0.20 0.02 0 20 0 20 0.33 1.00 0.73 0.01'

0.53 0.4?

0.73 0 53 0.4'7 0.40

0.0.' 0.44) 0.3') 0 4!? 0.30 0 30 0.02 0.02 0 07 0 . 2'1 0.19

0.2f) 0.20 0.31) 0.20 0.0'' 0 311 0.02 0 . 20 0.02 0.07 0 02 0 02 0 02

111. STEROIDSAPOGEXIXS AXD DERIVATIVES Sarsasapogenin N2. Diosgenin acetate 13.5 0.13 14.0 0 13 12 0 0 20 9.41 0.13 9.82 0.39 7.03 0.l3 8.59 0.40 6.11 0 ,s 7.63 0.30 5.72 1.0'1 6.94 0 40 5.44 0.03 5.54 1 00 r, 21 0 .40 4.98 0.53 4.72 0 40 4 62 0.40 4.38 0.40 4.48 0.53 3.AS 0 30 4,!5 0.20 3.19 03') 3 49 0.30 3 05 0.29 3.82 0.02 2.82 0 I3 3 . 75 0.30 2.04 0.03 3.5.5 0.30 2.53 0.07 3.33 0.13 2.38 0.03 3.02 0.40 2.31 0.07

2.86 2.74 2.59 2.4.5 2.32 2.22 2.17 2.10 2.02

0.07 0.07 0.30 0.13 0.07 0.20 0.20 0.20 0.20

d, A. I/I; N3. Cholesterol digitonide 14.09.ct 7.73 6.13

5 2U 4.42 3.87 3.G0 3 34 2 !IP

0.03 0.07 0 03 0.03 0 03

d , A.

d , A.

I/I, @-Sitosterol digitonide 14.0 0.20 11.7 0.01 7.73 0.15 8.63 0.02 7.66 0 I5 7.14 0.10 6.15 1 00 5.72 0.27 0 27 5.04 4.21 0 13 0 20 3.82 0.15 3.60 3.35 0.10 3.05 0.10 2.56 0.03 0.02 2.45 2.11 0.01 2.00 0 01

h-4.

0.40 0.30 0.30 1.00 0.53 0.07 0.13 0.13 0.07 0.07

IV. 0 1 . Gitoxin 13 7 0.20 9.41 0.09 0.36 7.00 6.49 1 .oo 5.79 0.67 B.47 0.49 5.20 0.01 5.05 1.00 4.81 0.01 4.63 0.36 4.34 0.36 4.10 0.36 3 96 0.30 3.78 0 36 3.63 0.36 3.40 0.36 3 26 0.36 0.36 3.19 3.08 0.20 2.95 0.13 2.87 0.13 2.75 0.36 2.69 0.04 2 G3 0.04 2.54 0.09 2 48 0.01 2.41 0.09 2.32 0.09 2 2i 0.01 2.22 0.01 0.27 2.18 2.10 0 01 2 03 0.27 2.02 0.01 0.01 1.97 1.90 0.01 1 sr, 0.09

2,14 2.05 1.97 1.86 1.71

I'I.

S5. A5-Androsten~ benzoate digitonide

13.7 11.2 9.71 7.63 6.92 6.09 5.4g 5.03 4 21 3.87 3.01 3.3n 3 13

'

0.56 0.03 0.38 0.03 0.56 1.00 0.23 1.00 0.56 0.7.5 0.56 0.13 0 13

DIGITALIS GLYCOSIDES

02. 12.0 10.8 8.98 7.17 6.09 5.63 5.29 5.11 4.66 4.43 4.17 3.98 3.78 3.59 3.47 3.32 3.21 3.08 2.90 2.91 2.74 2.59 2.46 2.31 2.23 2 15 2.09 2.05 1.99 1.94 1.90 1.83 1.78 1.74 1.70 1.64

Digoxin

0 13 0 20

0 13 0 36 0 67 0 09 1 00 1 00 0 13 0 36 0 27 0 27 0 13 0 09 0 20 0 02 0 27 0 20 0 13 0 13 0 04 0 20 0 20 0 13 0 13 0 13 0 13 0 13 0 01 0 09 0 13 0 09 0 02 0 09 0 01 0 01

03. 15.0 9 0i 8.01 7.28 7.00 6.26 5.9.5 5.63 5.32 5.00 4.80 4.172 4.32 4.10 3.93 3.73 3.62 3.52 3.39 3.30 3.23 3.06 2.89 2 75 2.60 2.52 2.43 2.37 2.20 2 10 2 0: 2 01 1.95

Digitoxifi 0 07 0 21J 0 0: 0 3'1 0 30 0 '40 1 00 0 53 0 13 0 40 0 40 0 40 0 73 0 30 0 30 0 30 0 07 0 07 0 0: 0 20 0 07 0 07 0 0: 0 0i 0 03 0 02 0 03 0 02 0 02 0 01 0 02 0 0' 0 01

N1.

ACKNOWLEDGMENT

The authors would like to acknowledge the assistanceof XIorioii Smale in the preparation of the x-ray data and photographs. LITERATURE CITED

(1) Haiiawalt, J. D . , R i n n , H. W.,a n d Frevel, L. K., TND. Esc;. CHEY.,-4s.4~.ED.,10, 457 (1935). (2) Klrlg, H. P., a n d Alexander, L. E., "X-Ray Diffraction Proeedures." p. 365, Wiley, Xew York, 1954. (3) Parsons. J.. and Beher, W. T., Aiv.4~.CHEY.,27, 514 (1955.. R F c E i r F n for review M a y 9, 1953.

Accepted J u n e 1. 1955.